Genomics Market Poised to Garner Maximum Revenue

Logo

Seattle, WA -- (SBWire) -- 09/27/2019 --Genomics is the study of human genes and chromosomes. It focuses on structure, function, evolution, mapping, and editing of genomes. Genome is the genetic material of organism, which includes the Deoxyribonucleic acid (DNA). DNA consists the information needed to build the whole human body. Human genome consists of 23 pairs of chromosomes and 24000 genes. This study is divided into various types such as structural genomics, functional genomics, and comparative genomics.

Increasing new product launches is expected to drive the global genomics market growth. For instance, in January 2019, Contextual Genomics launched two molecular hotspot assays (Liquid Biopsy Test and updated Solid Tumor Panel) for the detection of genomic mutations in blood and solid tumors. Furthermore, in May 2015, Rosetta Genomics Ltd. launched OncoGxOne. It is Next Generation Sequencing (NGS) test that profiles tumors for targeted therapy selection and chemotherapeutic tolerance.

Moreover, in September 2018, Zenome launched the first decentralized genomic internet software, which is expected to increase possibilities of safe storage of large amount of genetic data. The main advantage of decentralized genomic internet software is that the degree of security is much higher.

Request Sample Copy of this Report - https://www.coherentmarketinsights.com/insight/request-sample/2660

Lack of qualified and trained professionals in genomics study is a major challenge for the global genomics market growth. For instance, in January 2019, according to express healthcare report, genomics study needs highly qualified and trained professionals to optimize lab workflows and run it efficiently.

Europe is expected to gain significant share in the global genomics market over the forecast period, owing to increasing launches of new products by key players. For instance, in April 2017, Illumina, Inc. announced launch of its new product VeriSeq NIPT Solution, it is a CE-IVD marked next-generation sequencing (NGS)-based approach to non-invasive prenatal testing (NIPT).This approach includes the CE-IVD marked library preparation and analysis software. This software enables fast, highly accurate, cost-effective, and non-invasive parenteral testing (NIPT).

Furthermore, Asia Pacific is also projected to witness significant growth in the global genomics market during the forecast period, owing to increasing collaboration activities by key players. For instance, in January 2018, 10X Genomics, Inc. collaborated with the Berry Genomics Co. Ltd. Under this collaboration, 10x Genomics, Inc. focuses on development of approaches for next generation non-invasive prenatal testing (NIPT) and developing and offering new services for Berry Genomics Co. Ltd.

Get Discount for This Report - https://www.coherentmarketinsights.com/insight/request-discount/2660

Global Genomics Market Taxonomy

By Product Type

Consumables
Software and Services
Others
By Technology

PCR
Microarray
Next Gene Sequencing
Nucleic Acid Extraction and Purification
Others

By Application

Diagnostics
Drug Discovery and Development
Precision Medicine
Agriculture & Animal Research
Others

By End Users

Academic and Research Institute
Pharmaceutical and Biotech Companies
Hospital and Clinics
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East
Africa

Key players operating in the global genomics market include Thermo Fisher Scientific, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Illumina, Inc., Pacific Biosciences, Oxford Nanopore Technologies., 23andMe, Inc., Foundation Medicine, Inc. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.

To view the original version on The Express Wire visit https://www.coherentmarketinsights.com/ongoing-insight/genomics-market-2660

About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Media Relations Contact

Mr.Shah
CEO
Coherent Market Insights
1-206-701-6702
https://www.coherentmarketinsights.com/ongoing-insight/genomics-market-2660

View this press release online at: http://rwire.com/1261195